Comparing the results in Fig. 1 with Supplementary Figure 2, we found that the bioactivities against tumor cell proliferation and NF-κB activation of RA-V have good positive correlation in vitro, which drove us to investigate whether RA-V suppresses tumor growth in vivo by inhibiting NF-κB activation. This evidence concerns the gene NFKB1 and neoplasm.